miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy (Q34996775)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

1 reference

based on heuristic

inferred from title

George A. Calin

7

object named as

George Calin

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

author name string

Liana Adam

1

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Meng Zhong

2

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Woonyoung Choi

3

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Wei Qi

4

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Milena Nicoloso

5

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Ameeta Arora

6

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Hua Wang

8

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Arlene Siefker-Radtke

9

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

David McConkey

10

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Menashe Bar-Eli

11

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Colin Dinney

12

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

language of work or name

0 references

publication date

11 August 2009

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

15

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

16

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

5060-5072

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

The cadherin superfamily.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Emerging drugs for targeted therapy of bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Mig-6, signal transduction, stress response and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Molecular correlates of gefitinib responsiveness in human bladder cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

MicroRNA signatures in human cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

MicroRNA biogenesis: isolation and characterization of the microprocessor complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Phosphotyrosine interactome of the ErbB-receptor kinase family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Oncomirs - microRNAs with a role in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Human RISC couples microRNA biogenesis and posttranscriptional gene silencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Bladder cancer stage and outcome by array-based comparative genomic hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Focus on bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Negative regulation of ErbB family receptor tyrosine kinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Feedback inhibition by RALT controls signal output by the ErbB network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Trafficking of the ErbB receptors and its influence on signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Isolation and Characterization of Metastatic Variants from Human Transitional Cell Carcinoma Passaged by Orthotopic Implantation in Athymic Nude Mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

13 July 2018

Expression-targeted gene therapy for the treatment of transitional cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

26 October 2018

E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

26 October 2018

Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

26 October 2018

Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5938624

26 October 2018

Advanced bladder cancer: so many drugs, so little progress : what's wrong with this picture?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19671845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/19671845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-08-2245

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

release_fthf643srzc65apqp5rzyyp5je

1 reference

https://api.fatcat.wiki/v0/release/fthf643srzc65apqp5rzyyp5je

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 July 2018

http://europepmc.org/abstract/PMC/5938624

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34996775&oldid=1844355226"